HDFC MF and ADIA Lead ₹777 Crore Block Deal in Corona Remedies

A significant shift in the ownership structure of Corona Remedies Limited took place as major institutional players moved to acquire a substantial stake in the pharmaceutical company. Through a massive block deal, marquee global and domestic investors have stepped in to absorb shares offloaded by existing high-profile holders.

Major Divestments by Sepia Investments and Anchor Partners

On June 17, 2026, the stock exchange witnessed a high-value liquidity event involving Corona Remedies. The primary seller, Sepia Investments, offloaded a massive block of 43,28,943 shares. These shares were transacted at a price of ₹1,730 per share, amounting to a deal value of approximately ₹748.9 crore.

In addition to Sepia, another seller, Anchor Partners, participated in the divestment by selling 1,61,861 shares at the same price point of ₹1,730. This secondary sale contributed an additional ₹28 crore to the total transaction. Collectively, the two sellers divested shares worth roughly ₹776.9 crore, marking one of the most significant block deals in the pharmaceutical sector for the period.

HDFC Mutual Fund Dominates the Buy Side

The exit of Sepia and Anchor Partners was met with aggressive buying interest from a diverse group of twelve institutional investors. HDFC Mutual Fund emerged as the most dominant participant in this transaction, acquiring 24,50,000 shares. This single purchase, valued at approximately ₹423.9 crore, accounted for more than half of the total deal value, signaling strong domestic confidence in the company's prospects.

Other significant domestic players included Aditya Birla Sun Life Mutual Fund, which picked up 4,90,000 shares worth ₹84.8 crore, and Kotak Mahindra Mutual Fund, which acquired 1,61,861 shares worth ₹28 crore—matching the exact volume sold by Anchor Partners.

Global Institutions and Foreign Portfolio Interest

The deal also saw heavy participation from international funds, highlighting the global interest in Corona Remedies. Aberdeen Asset Management entities were prominent, with Aberdeen Asian Smaller Companies Investment Trust Plc purchasing 4,50,868 shares worth roughly ₹78 crore. Additionally, the Aberdeen Standard Sicav I - Asian Smaller Companies Fund added 2,74,132 shares (₹47.4 crore) to its portfolio.

글로벌 대형 투자사인 아부다비 투자청(ADIA)도 참여하여 약 6,800만 루피 상당의 주식 39,130주를 인수했습니다. 다른 해외 투자자로는 Invesco Mutual Fund(5억 루피), WhiteOak Capital Mutual Fund(2억 5,100만 루피), 그리고 TCW White Oak Emerging Markets Equity Fund가 포함되었습니다. TCW White Oak Emerging Markets Equity Fund는 1,920주를 매수한 가장 작은 규모의 구매자였음에도 불구하고 전체적인 기관 투자 모멘텀에 기여했습니다.

핵심 요약